Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases,
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …

Background We describe an outbreak of gastroenteritis and the hemolytic–uremic syndrome
caused by Shiga-toxin–producing Escherichia coli in Germany in May, June, and July, 2011…

Angiotensin converting enzyme 2 (ACE2) is the crucial severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) receptor and protects multiple tissues, including the lung, from …

Superspreading events shaped the coronavirus disease 2019 (COVID-19) pandemic, and
their rapid identification and containment are essential for disease control. Here, we provide a …

CD8 + T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus
control. Here, we identified nonsynonymous mutations in MHC-I-restricted CD8 + T cell …

Background Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with
a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against …

Methods We measured enzymatically active plasma ACE2 concentration (subsequently
referred to as “ACE2”) and key RAS metabolites in 532 blood samples obtained from 126 …

The informal recycling of electronic waste (e-waste) is an emerging source of environmental
pollution in Africa. Among other toxins, polycyclic aromatic hydrocarbons (PAHs) are a …

Background. AIDS‐related lymphoma contributes to significant morbidity and mortality
among human immunodeficiency virus (HIV)–infected patients receiving highly active …

Purpose Host genetic variants may contribute to severity of COVID-19. NKG2C + NK cells
are potent antiviral effector cells, potentially limiting the extent of SARS-CoV-2 infections. …